All compounds described on this website are supplied strictly for in-vitro laboratory research. They are not for human or veterinary use, and no medical or therapeutic claims are made.
Research category
Incretin analogues and other compounds studied in the context of glucose regulation, appetite signalling and body-weight physiology — several of which are approved medicines in their licensed forms.
Every compound below is supplied at 99% purity (HPLC) for in-vitro laboratory research. Open a profile for technical data, research background and references, or enquire to order directly.
Metabolic Research99% purityTriple GIP/GLP-1/glucagon receptor agonist (investigational peptide)
An investigational single-molecule agonist of the GIP, GLP-1 and glucagon receptors, currently in late-stage clinical development. Not an approved medicine anywhere as of this profile.
Metabolic Research99% purityAcylated GLP-1 receptor agonist (31-amino-acid analogue)
A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. In its licensed pharmaceutical forms it is an approved medicine; as a research compound it is used to study incretin signalling, appetite regulation and glucose homeostasis.
Metabolic Research99% purityDual GIP/GLP-1 receptor agonist (39-amino-acid acylated peptide)
A single-molecule dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors. Licensed as a medicine in several jurisdictions; used in research to study multi-receptor incretin pharmacology.
Metabolic Research99% puritySynthetic 16-amino-acid fragment of human growth hormone (C-terminal, disulfide-bridged)
A modified C-terminal fragment of human growth hormone, investigated in the 1990s–2000s for lipolytic activity without the growth-promoting effects of the full hormone. Clinical development was discontinued.
For laboratory research only. All compounds described on this website are supplied strictly for in-vitro laboratory research. They are not for human or veterinary use, and no medical or therapeutic claims are made. Researchers remain responsible for complying with the rules that apply to them.
Full disclaimer